Cargando…
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
PURPOSE: The ENFORCE cohort is a national Danish prospective cohort of adults who received a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine as part of the Danish National SARS-CoV-2 vaccination programme. It was designed to investigate the long-term effectiveness, safety and du...
Autores principales: | Stærke, Nina Breinholt, Reekie, Joanne, Johansen, Isik S, Nielsen, Henrik, Benfield, Thomas, Wiese, Lothar, Søgaard, Ole S, Tolstrup, Martin, Iversen, Kasper Karmark, Tarp, Britta, Larsen, Fredrikke Dam, Larsen, Lykke, Lindvig, Susan Olaf, Holden, Inge Kristine, Iversen, Mette Brouw, Knudsen, Lene Surland, Fogh, Kamille, Jakobsen, Marie Louise, Traytel, Anna Katrin, Ostergaard, Lars, Lundgren, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809224/ https://www.ncbi.nlm.nih.gov/pubmed/36585137 http://dx.doi.org/10.1136/bmjopen-2022-069065 |
Ejemplares similares
-
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)
por: Bannister, Wendy P, et al.
Publicado: (2023) -
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study
por: Søgaard, Ole Schmeltz, et al.
Publicado: (2022) -
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022) -
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study
por: Baerends, Eva A M, et al.
Publicado: (2023) -
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
por: Dietz, Lisa Loksø, et al.
Publicado: (2023)